Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 6 de 6
Filtrar
Mais filtros










Base de dados
Intervalo de ano de publicação
1.
Neurochem Res ; 28(3-4): 461-5, 2003 Apr.
Artigo em Inglês | MEDLINE | ID: mdl-12675131

RESUMO

NGF modifies cholinergic neurons through its low-p75 and high affinity-TrkA receptors. Native p75(+)TrkA(-) and trkA-transfected p75(+)TrkA(+) SN56 hybrid cholinergic septal cells were used here to discriminate effects mediated by each receptor. In TrkA(-) cells, NGF (100 ng/ml) affected neither choline acetyltransferase nor morphology but depressed pyruvate dehydrogenase activity by about 30%. Aged 25-35 beta-amyloid (1 microM) caused no changes in choline acetyltransferase and pyruvate dehydrogenase activities in nondifferentiated and differentiated TrkA(-) cells. On the contrary, in nondiferentiated TrkA(+) NGF brought about a 2.5-fold increase of choline acetyltransferase. In differentiated TrkA(+) cells, beta-amyloid resulted in no change in PDH but 65% suppression of choline acetyltransferase activity and reduction of their extensions. Thus, activation of TrkA receptors may overcome p75 receptor-mediated inhibitory effects on pyruvate dehydrogenase expression in cholinergic cells. On the other hand, it would make expression of choline acetyltransferase and cell differentiation more susceptible to suppressory effects of beta-amyloid.


Assuntos
Acetilcolina/metabolismo , Peptídeos beta-Amiloides/farmacologia , Neurônios/metabolismo , Neurônios/patologia , Receptor trkA/fisiologia , Receptores de Fator de Crescimento Neural/fisiologia , Animais , Diferenciação Celular/fisiologia , Sobrevivência Celular/efeitos dos fármacos , Colina O-Acetiltransferase/metabolismo , Camundongos , Fator de Crescimento Neural/farmacologia , Neuroblastoma/metabolismo , Neuroblastoma/patologia , Neurônios/efeitos dos fármacos , Neurônios/fisiologia , Complexo Piruvato Desidrogenase/metabolismo , Receptor de Fator de Crescimento Neural , Células Tumorais Cultivadas
2.
J Neurosci Res ; 62(4): 615-22, 2000 Nov 15.
Artigo em Inglês | MEDLINE | ID: mdl-11070506

RESUMO

Mechanisms of preferential loss of cholinergic neurons in the course of neurodegenerative diseases are unknown. Therefore, we investigated whether differentiation-evoked changes in acetyl-CoA and acetylcholine metabolism contribute to the susceptibility of cholinergic neuroblastoma to cytotoxic effects of Al. In SN56 cells differentiated with retinoic acid and dibutyryl cAMP (DC), pyruvate utilization and acetyl-CoA content were lower and acetylcholine level higher than in nondifferentiated cells (NC), respectively. In DC Al and Ca accumulations were 50% and 100%, respectively higher than in NC. Acute Al addition caused inhibition, whereas its chronic application had no effect on pyruvate utilization both in NC and in DC. On the other hand, in both experiments, Al evoked a greater decrease of acetyl-CoA level in DC than in NC. Acute addition of Al depressed acetylcholine release from DC to two times lower values than in NC. On the other hand, chronic addition of Al increased ACh release from DC over twofold, being without effect on its release from NC. These findings indicate that higher accumulation of Ca, along with low levels of acetyl-CoA, could make DC more susceptible to neurotoxic inputs than NC. Excessive acetylcholine release, evoked by Al, is likely to increase acetyl-CoA utilization for resynthesis of the neurotransmitter pool and cause deficit of this metabolite in DC. On the other hand, NC, owing to lower Ca accumulation, slower ACh metabolism, and higher level of acetyl-CoA, would be less prone to these harmful conditions.


Assuntos
Acetilcoenzima A/efeitos dos fármacos , Acetilcolina/metabolismo , Alumínio/toxicidade , Diferenciação Celular/efeitos dos fármacos , Degeneração Neural/induzido quimicamente , Doenças Neurodegenerativas/induzido quimicamente , Células Tumorais Cultivadas/efeitos dos fármacos , Acetilcoenzima A/metabolismo , Alumínio/metabolismo , Animais , Cálcio/metabolismo , Diferenciação Celular/fisiologia , Fibras Colinérgicas/efeitos dos fármacos , Fibras Colinérgicas/metabolismo , Fibras Colinérgicas/patologia , Enzimas/efeitos dos fármacos , Enzimas/metabolismo , Humanos , Líquido Intracelular/efeitos dos fármacos , Líquido Intracelular/metabolismo , Camundongos , Camundongos Endogâmicos C57BL , Degeneração Neural/metabolismo , Degeneração Neural/fisiopatologia , Neuroblastoma , Doenças Neurodegenerativas/metabolismo , Doenças Neurodegenerativas/fisiopatologia , Neurônios/efeitos dos fármacos , Neurônios/metabolismo , Neurônios/patologia , Fenótipo , Fatores de Tempo , Células Tumorais Cultivadas/citologia , Células Tumorais Cultivadas/metabolismo
3.
Metab Brain Dis ; 15(1): 29-44, 2000 Mar.
Artigo em Inglês | MEDLINE | ID: mdl-10885539

RESUMO

Cholinergic neurons, unlike other brain cells utilize acetyl-CoA not only for energy production but also for acetylcholine (ACh) synthesis. Therefore, suppression of acetyl-CoA metabolism by different neurotoxic inputs may be particularly harmful for this group of cells. Differentiation of SN56 cholinergic hybrid cells increased their choline acetyltransferase (ChAT) activity and ACh content but depressed pyruvate dehydrogenase activity and acetyl-CoA content. Differentiated cells were more susceptible to acute and chronic influences of aluminum, NO and amyloid-beta. Al decreased acetyl-CoA content, ACh release and increased Ca accumulation in differentiated cells (DC) to much higher degree than in non-differentiated ones (NC). NO strongly depressed acetyl-CoA level and increased ACh release in DC but did not affect NC. Additive effects of Al and NO were seen in DC but not in NC. Also long term suppressory effects of amyloid-beta, Al and NO on cholinergic phenotype and morphologic maturation were more evident in DC than in NC. Thus, relative shortage of acetyl-CoA in highly differentiated cholinergic neurons could make them particularly susceptible to degenerative insults in the course of different cholinergic encephalopathies.


Assuntos
Acetilcoenzima A/metabolismo , Acetilcolina/metabolismo , Colina O-Acetiltransferase/metabolismo , Neurônios/fisiologia , Neurotoxinas/farmacologia , Alumínio/farmacologia , Peptídeos beta-Amiloides/farmacologia , Animais , Diferenciação Celular , Células Cultivadas , Resistência a Medicamentos , Células Híbridas , Camundongos , Camundongos Endogâmicos C57BL , Neurônios/citologia , Neurônios/metabolismo , Óxido Nítrico/farmacologia , Doadores de Óxido Nítrico/farmacologia , Nitroprussiato/farmacologia , Fragmentos de Peptídeos/farmacologia , Fatores de Tempo , Células Tumorais Cultivadas
4.
Planta Med ; 65(6): 572-3, 1999 Aug.
Artigo em Inglês | MEDLINE | ID: mdl-10532874

RESUMO

From the leaves of Cupressocyparis leylandii (Cupressaceae) cupressuflavone, 4-O-methylcupressuflavone, amentoflavone, 7-O-methylamentoflavone, 4-O-methylamentoflavone and hinokiflavone were isolated. 1H- and 13C-NMR data for 4-O-methylcupressuflavone are given for the first time. The biflavones from cultivar varieties of C. leylandii (Naylor's Blue, Castlewellan Gold) were chromatographicaly (HPLC) compared. The antifungal activity of cupressuflavone and 4-O-methylcupressuflavone against Alternaria alternata, Cladosporium oxysporum, Fusarium culmorum and F. avenaceum was assayed.


Assuntos
Antifúngicos/química , Flavonoides/química , Extratos Vegetais , Alternaria/efeitos dos fármacos , Antifúngicos/isolamento & purificação , Antifúngicos/farmacologia , Cladosporium/efeitos dos fármacos , Flavonoides/isolamento & purificação , Flavonoides/farmacologia , Fusarium/efeitos dos fármacos , Testes de Sensibilidade Microbiana , Folhas de Planta
5.
Postepy Hig Med Dosw ; 53(2): 263-75, 1999.
Artigo em Polonês | MEDLINE | ID: mdl-10355292

RESUMO

Preferential loss of cholinergic neurons in course of several encephalopathies may result from the fact that they utilize acetyl-CoA not only for energy production, but also for acetylcholine synthesis. Changes in activities of acetyl-CoA metabolizing enzymes and shifts in acetyl-CoA compartmentalization, found in different animal models of brain pathologies and in human post mortem brain, are discussed in therms of their impact on cholinergic system integrity.


Assuntos
Encefalopatias/metabolismo , Fibras Colinérgicas/fisiologia , Neurônios/metabolismo , Acetilcoenzima A/metabolismo , Acetilcolina/biossíntese , Alumínio/toxicidade , Animais , Encefalopatias/induzido quimicamente , Encefalopatias/patologia , Fibras Colinérgicas/efeitos dos fármacos , Neuropatias Diabéticas/metabolismo , Modelos Animais de Doenças , Metabolismo Energético , Humanos , Neurônios/efeitos dos fármacos
6.
J Neurochem ; 71(6): 2447-53, 1998 Dec.
Artigo em Inglês | MEDLINE | ID: mdl-9832143

RESUMO

Al complexes are known to accumulate in extra- and intracellular compartments of the brain in the course of different encephalopathies. In this study possible effects of Al accumulation in the cytoplasmic compartment on mitochondrial metabolism were investigated. Al, like Ca, inhibited pyruvate utilization as well as citrate and oxoglutarate accumulation by whole brain mitochondria. Potencies of Ca2+(total) effects were 10-20 times stronger than those of Al. Al decreased mitochondrial acetyl-CoA content in a concentration-dependent manner, along with an equivalent rise of free CoA level, whereas Ca caused loss of both intermediates from mitochondria. In the absence of Pi in the medium, Ca had no effect on mitochondrial metabolism, whereas Al lost its ability to suppress pyruvate utilization and acetyl-CoA content in Ca-free conditions. Verapamil potentiated, whereas ruthenium red reversed, Ca-evoked suppression of mitochondrial metabolism. On the other hand, in Ca-supplemented medium, Al partially overcame the inhibitory influence of verapamil. Accordingly, verapamil increased mitochondrial Ca levels much more strongly than Al. However, Al partially reversed the verapamil-evoked rise of Ca2+(total) level. These data indicate that Al accumulated in cytoplasm in the form of the Al(PO4)OH- complex may inhibit mitochondrial functions by an increase of intramitochondrial [Ca2+]total resulting from the Al-evoked rise of cytoplasmic [Ca2+]free, as well as from inhibitory interference with the verapamil binding site on the Na+/Ca2+ antiporter.


Assuntos
Acetilcoenzima A/metabolismo , Alumínio/farmacologia , Encéfalo/metabolismo , Cálcio/farmacologia , Mitocôndrias/metabolismo , Alumínio/análise , Animais , Cálcio/análise , Bloqueadores dos Canais de Cálcio/farmacologia , Meios de Cultura/análise , Masculino , Ratos , Ratos Wistar
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA
...